United States In-vitro Cancer Diagnostics Market: AI, Molecular Testing, and Next-Gen Solutions | Top Companies are Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA

In-vitro Cancer Diagnostics Market is valued at a significant CAGR during the forecast period (2024-2031). As per DataM Intelligence Database.

The In-vitro Cancer Diagnostics Market focuses on laboratory tests conducted outside the human body to detect, monitor, and predict cancer progression. These diagnostics include biomarker assays, genetic tests, and immunoassays. Market growth is driven by rising cancer incidence, increasing demand for early detection, and advancements in molecular diagnostic technologies. Hospitals, diagnostic laboratories, and research institutions are key end-users. Precision medicine initiatives and regulatory support further enhance market adoption.

📌 Download Sample Report to Identify Emerging Deals & Opportunities in the In-vitro Cancer Diagnostics Market Landscape:- https://datamintelligence.com/download-sample/in-vitro-cancer-diagnostics-market?rk

☛ In-vitro Cancer Diagnostics Market Recent Developments 2025:

United States: Recent Industry Developments

✅ In May 2025, Illumina partnered with Pillar Biosciences to offer the oncoReveal CDx IVD kit, enabling detection of genetic variations in 22 genes for solid tumor patients. This collaboration expands Illumina's oncology diagnostics portfolio.

✅ In April 2025, Pillar Biosciences announced that the oncoReveal CDx received nationwide Medicare coverage by the Centers for Medicare & Medicaid Services (CMS), enhancing accessibility for patients requiring genetic testing.

✅ In January 2025, Foresight Diagnostics received Investigational Device Exemption (IDE) approval from the FDA for the use of Foresight CLARITYTM in the ALPHA3 clinical trial, marking a significant milestone in lymphoma diagnostics.

Japan: Recent Industry Developments

✅ In April 2025, the National Cancer Center Japan launched the "ARCAD-Gastric" global clinical trial database project, aiming to enhance gastric cancer research and treatment strategies.

✅ In March 2025, the National Cancer Center Japan introduced new radiopharmaceuticals for renal cell carcinoma, advancing therapeutic options for this challenging cancer type.

✅ In July 2025, a report identified 31 in-vitro diagnostics startups in Japan, including companies like HORIBA, Craif, and Lily MedTech, indicating a vibrant and innovative diagnostic ecosystem.

☛ In-vitro Cancer Diagnostics Market Trends:

The in-vitro cancer diagnostics market is growing due to rising cancer prevalence, increasing demand for early detection, and advancements in molecular and genomic diagnostic techniques. Expanding healthcare infrastructure in emerging markets is also supporting market growth.

Trends include liquid biopsy technologies for non-invasive diagnostics, development of multiplex assays for multiple biomarkers, AI-assisted diagnostic platforms, and personalized diagnostic solutions aligned with targeted therapies.

☛ In-vitro Cancer Diagnostics Market Competitve Landscape:

Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche AG, Siemens AG, QIAGEN N.V., Sysmex Corporation, and Thermo Fisher Scientific, Inc.

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/in-vitro-cancer-diagnostics-market

☛ Segment Covered in the In-vitro Cancer Diagnostics Market:

By Product Type: Reagents | Instruments | Others

By Technique Type: Molecular Diagnostics | Clinical Chemistry | Point-Of-Care | Others

By End-User: Hospital Associated Labs | Cancer Research Institutes | Diagnostic Imaging Centers | Others

☛ This Report Includes:

✔ Comprehensive go-to-market strategies with actionable insights.

✔ Unbiased evaluation of overall market performance.

✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.

✔ Tailored regional and country-level reports with detailed localized analysis available on request.

✔ Identification of niche segments and high-growth regions presenting strong opportunities.

✔ Accurate regional forecasts using both top-down and bottom-up approaches.

📌 Get Corporate Access to Live In-vitro Cancer Diagnostics Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=in-vitro-cancer-diagnostics-market

☛ Regional Analysis for In-vitro Cancer Diagnostics Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

☛ Frequently asked questions:

➠ What is the global sales, production, consumption, import, and export value of the In-vitro Cancer Diagnostics Market?
➠ Who are the key global manufacturers, and what is their operational performance?
➠ What are the major opportunities and threats in the global In-vitro Cancer Diagnostics Market?
➠ Which product types or end-users show the most growth potential and market share?
➠ What challenges and constraints are impacting the In-vitro Cancer Diagnostics Market?
➠ What sales, marketing, and distribution channels are used globally?

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.